绝经后骨质疏松症的适宜治疗方法是什么？
[What is appropriate in postmenopausal osteoporosis?].
作者信息
Jesserer H
机构信息
II. Medizinischen Abteilung, des Kaiser-Franz-Joseph-Spitals Wien.
出版信息
Z Gesamte Inn Med. 1988 Aug 1;43(15):416-8.
PMID:3051742
Abstract
The term of postmenopausal osteoporosis created 1940/1941 by Albright and his coworkers corresponds on our days no more to the original conception, because it is used now in a broader form. The resulting practical consequences, e.g. the postulates of a general medical prophylaxis, induce a new discussion which is adapted to the scientific state of to-day and the real importance.
摘要
1940年/1941年由奥尔布赖特及其同事提出的绝经后骨质疏松症这一术语，如今已不再符合其最初的概念，因为现在它的使用范围更广了。由此产生的实际后果，例如一般医学预防的假设，引发了一场适应当今科学状况和实际重要性的新讨论。
相似文献
1
[What is appropriate in postmenopausal osteoporosis?].
Z Gesamte Inn Med. 1988 Aug 1;43(15):416-8.
2
Prevention of postmenopausal osteoporosis by estrogen/gestagen substitution therapy.
Med Klin (Munich). 1987 Mar 20;82(6):238-41.
3
Hormone replacement therapy and cancer.
Br J Hosp Med. 1989 Feb;41(2):142, 144-6, 148-9.
4
[General undifferentiated estrogen (progestagen) substitution in the prevention of osteoporosis: contra].
Med Klin (Munich). 1987 Mar 20;82(6):241-4.
5
[Oral hormone therapy in pre- and postmenopause].
Med Klin (Munich). 1990 Apr 15;85(4):200-5.
6
Preventing postmenopausal osteoporosis with estrogen replacement therapy.
Int J Fertil. 1986;31(3 Suppl [ESTROGEN]):15-20.
7
Physicians changing postmenopausal sex hormone prescribing regimens.
Prog Clin Biol Res. 1986;216:325-35.
8
[Hormone substitution by injectable preparations and skin implants].
Gynakologe. 1986 Dec;19(4):241-7.
9
[Substitute estrogen treatment of women after the menopause from the internist's viewpoint].
Pol Tyg Lek. 1985 Jul 29;40(30):852-4.
10
Optimizing the dose of hormone replacement therapy.
Int J Fertil Womens Med. 2002 Sep-Oct;47(5):205-10.
Zotero 插件